UTv Videos

"Mentorship plays a huge role, and as someone who's interested in academics in the future, I think it's important to remember the influence that you can have on shaping young minds," says Niki Parikh, MD, MBA, MSBA.

“The world of surgery makes a person quite disciplined,” says Martha Boone, MD.

"I would say the take-home message from this study is that HoLEP uptake has nearly doubled from 2016 to 2019," says Jenny Guo, MD.

“It's a really exciting time for people who are interested in BPH/LUTS,” says Dean S. Elterman, MD, MSc, FRCSC.

"Interestingly enough, we found that PVP accounted for nearly a third of BPH surgeries back in 2016. This number drastically decreased to just 0.7% of all BPH surgeries in 2019," says Jenny Guo, MD.

"Only 25% of our respondents felt that sexual health curriculum provided an adequate fund of knowledge to address any of the sexual health concerns of patients," says Niki Parikh, MD, MBA, MSBA.

"If you've got a difference, pay attention to the size and direction. If you have a massive difference between groups in terms of outcome, but only a small difference in terms of baseline characteristics, that's worth talking about," says Andrew J. Vickers, PhD.

“Our identity is not just about a title; it's not just about that role. We are much bigger than that,” says Diana Londoño, MD.

"We had the idea of doing a scoping review of office-based BPH stents, as this is becoming a new and evolving hot topic in the area of male functional urology," Dean S. Elterman, MD, MSc, FRCSC.

“In terms of trying to help patients access the services, the biggest part is just being aware of what's available where you work,” says Sarah P. Psutka, MD, MS.

“I think it's extremely exciting to be part of something that is possibly practice changing, potentially field changing,” says Sandip M. Prasad, MD, MPhil.

“It's really important to pay attention to what's off balance,” says Diana Londoño, MD.

"We're interested in cause; that's why we often are doing observational research. Authors never face that head on, and don't really come to grips with it," says Andrew J. Vickers, PhD.

“I can tell you from a patient standpoint, I think we all agreed across the panel, there's going to be tremendous enthusiasm from patients about a nonsurgical option,” says Sandip M. Prasad, MD, MPhil.

"Given the time constraints and financial constraints of working in the systems that we all work within, trying to make it easier to get patients to these adjuvant services that do exist and making sure we capitalize and utilize those is critical," says Sarah P. Psutka, MD, MS.

“I think it's a very novel finding, and something completely new to urologic oncology, that a nonsurgical ablative option inside the body can actually make tumors go away,” says Sandip M. Prasad, MD, MPhil.

“I didn't want to only get coached; I thought, "Well, if I become a coach, maybe I can share this with others,” says Diana Londoño, MD.

"The one other thing that we think might be helpful is that for labs that are reporting free PSA results, the most value seems to be if you report from a PSA of 2 to 10," says Mark A. Preston, MD, MPH.

“[As] urologists and physicians, we should all appreciate AI's potential, but also understand its current limitations,” says Roei Golan.

"The goal here is obviously to identify men who need investigation and diagnosis of prostate cancer and who we don't need to biopsy at all," says Mark A. Preston, MD, MPH.

"It's the first randomized trial that I'm aware of in urine markers looking at standard of care versus a marker-based approach," says Yair Lotan, MD.

"One of the things that we want to look at long-term is how the kidney being exposed to limited durations of warm ischemia compared to no ischemia at all affects longitudinal atrophy," says Carlos Muñoz-Lopez.

“Listen to your body; these are the signals telling you something is out of balance,” says Diana Londoño, MD.

"Having a framework in place anticipating somebody may want to have a child in the program helps a lot," says Christine Van Horn, MD.

Some patients with bladder cancer have been traveling to other regions for treatment if their location has no available cisplatin, explains Scott Tagawa MD.

“The primary thing we found was that the average kidney–and we study the ipsilateral kidney, or the kidney that was operated on–fell at the natural aging process,” says Carlos Muñoz-Lopez.

"Some women are perceived as being less serious because they chose to build a family in training," says Christine Van Horn, MD.

“ChatGPT isn't yet ready to determine the quality of online text, but I think it's going to change in the future,” says Roei Golan.